BioRegenx, Inc.
BRGX
$0.0129
$0.001917.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -394.90K | -3.55M | -704.80K | 445.20K | -2.52M |
| Total Depreciation and Amortization | 574.50K | 870.20K | 200.10K | -3.60K | 1.20K |
| Total Amortization of Deferred Charges | 8.60K | 24.80K | -- | 5.90K | -- |
| Total Other Non-Cash Items | -260.50K | 2.20M | 330.20K | 543.40K | 2.24M |
| Change in Net Operating Assets | 41.10K | 138.30K | 211.60K | 173.80K | -4.10K |
| Cash from Operations | -31.20K | -318.60K | 37.00K | 1.16M | -283.50K |
| Capital Expenditure | 0.00 | 399.00K | -588.40K | 51.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 1.40K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 18.45M | -18.45M | -- | -- |
| Cash from Investing | 0.00 | 18.85M | -19.04M | 51.40K | -- |
| Total Debt Issued | 56.80K | -205.50K | 637.50K | 12.80K | 71.20K |
| Total Debt Repaid | -10.30K | 62.00K | -91.50K | 144.20K | -18.30K |
| Issuance of Common Stock | -- | -- | -- | -- | 63.20K |
| Repurchase of Common Stock | -- | -- | -- | -815.10K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -18.44M | 18.44M | -- | -- |
| Cash from Financing | 46.40K | -18.58M | 18.99M | -658.10K | 116.10K |
| Foreign Exchange rate Adjustments | -2.60K | 500.00 | 1.00K | -- | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.70K | -56.80K | -11.20K | 558.10K | -167.40K |
